litlas
Log inCreate account

Faith E. Davies

Active 1997–2025

187
Papers
30,914
Citations
99
h-index
181
i10-index

Citations

Citations per year for Faith E. Davies1993: 3 citations1994: 1 citations1998: 2 citations1999: 3 citations2000: 3 citations2001: 31 citations2002: 105 citations2003: 135 citations2004: 167 citations2005: 185 citations2006: 164 citations2007: 190 citations2008: 167 citations2009: 187 citations2010: 162 citations2011: 242 citations2012: 236 citations2013: 283 citations2014: 282 citations2015: 268 citations2016: 247 citations2017: 288 citations2018: 269 citations2019: 969 citations2020: 1,113 citations2021: 1,070 citations2022: 882 citations2023: 503 citations2024: 850 citations2025: 377 citations2026: 8 citations1995–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,514 citing papers, 25.5% of this breakdownUnited Kingdom: 727 citing papers, 7.4% of this breakdownItaly: 674 citing papers, 6.8% of this breakdownGermany: 610 citing papers, 6.2% of this breakdownChina: 600 citing papers, 6.1% of this breakdownFrance: 510 citing papers, 5.2% of this breakdownSpain: 485 citing papers, 4.9% of this breakdownCanada: 312 citing papers, 3.2% of this breakdownNetherlands: 301 citing papers, 3.1% of this breakdownAustralia: 254 citing papers, 2.6% of this breakdownGreece: 233 citing papers, 2.4% of this breakdownBelgium: 206 citing papers, 2.1% of this breakdown
0%25.5%Other 24.5%

Institutions

Fields

  • Medicine71.1%
  • Biochemistry, Genetics and Molecular Biology21.8%
  • Immunology and Microbiology4.9%
  • Neuroscience0.3%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Computer Science0.3%
  • Other1.3%

Topics

  • Multiple Myeloma Research and Treatments19.1%
  • Protein Degradation and Inhibitors8.1%
  • Peptidase Inhibition and Analysis4%
  • Cancer Treatment and Pharmacology2.7%
  • Ubiquitin and proteasome pathways2.6%
  • CAR-T cell therapy research2.1%
  • Other61.4%

Coauthors

All papers

Open in search
  1. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

    Authors: Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, Cody Ashby, Michael Bauer, Faith E. Davies, Adam Rosenthal, Hongwei Wang, Pingping Qu, Antje Hoering, Mehmet Samur, Fadi Towfic, María Ortiz, Erin Flynt, Zhinuan Yu, Zhihong Yang, Dan Rozelle, John C. Obenauer, Matthew Trotter, Daniel Auclair, Jonathan J. Keats, Niccolò Bolli, Mariateresa Fulciniti, Raphaël Szalat, Philippe Moreau, Brian G.M. Durie, A. Keith Stewart, Hartmut Goldschmidt, Marc S. Raab, Hermann Einsele, Pieter Sonneveld, Jesús F. San Miguel, Sagar Lonial, Graham Jackson, Kenneth C. Anderson, Hervé Avet‐Loiseau, Nikhil Munshi, Anjan Thakurta, Gareth J. Morgan - Leukemia 2018 cited by 453

  2. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

    Authors: Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, Cody Ashby, Michael Bauer, Faith E. Davies, Adam Rosenthal, Hongwei Wang, Pingping Qu, Antje Hoering, Mehmet Samur, Fadi Towfic, María Ortiz, Erin Flynt, Zhinuan Yu, Zhihong Yang, Dan Rozelle, John C. Obenauer, Matthew Trotter, Daniel Auclair, Jonathan J. Keats, Niccolò Bolli, Mariateresa Fulciniti, Raphaël Szalat, Philippe Moreau, Brian G.M. Durie, A. Keith Stewart, Hartmut Goldschmidt, Marc S. Raab, Hermann Einsele, Pieter Sonneveld, Jesús F. San Miguel, Sagar Lonial, Graham Jackson, Kenneth C. Anderson, Hervé Avet‐Loiseau, Nikhil Munshi, Anjan Thakurta, Gareth J. Morgan - Blood 2018 cited by 495

  3. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

    Authors: Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil Begum, Nasrin M. Dahir, Paula Proszek, David C. Johnson, Martin Kaiser, Lorenzo Melchor, Lauren I. Aronson, Matthew Scales, Charlotte Pawlyn, Fabio Mirabella, John R Jones, Annamaria Brioli, Aneta Mikulášová, David A. Cairns, Walter M. Gregory, Ana Quartilho, Mark T. Drayson, Nigel H. Russell, Gordon Cook, Graham Jackson, Xavier Leleu, Faith E. Davies, Gareth J. Morgan - Journal of Clinical Oncology 2015 cited by 564

  4. A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

    Authors: Rakesh Popat, Torben Plesner, Faith E. Davies, Gordon Cook, Mark Cook, Peter J. Elliott, Eric Jacobson, Todd Gumbleton, Heather Oakervee, Jamie Cavenagh - British Journal of Haematology 2012 cited by 220

  5. Genomic Classification and Individualized Prognosis in Multiple Myeloma

    Authors: Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M. Poos, Andriy Derkach, Kylee Maclachlan, Michael Durante, Benjamin Diamond, Marios Papadimitriou, Faith E. Davies, Eileen M. Boyle, Brian A. Walker, Malin Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K. Teer, Erin M. Siegel, Niccolò Bolli, Graham Jackson, Martin Kaiser, Charlotte Pawlyn, Gordon Cook, Dickran Kazandjian, Caleb Stein, Marta Chesi, Leif Bergsagel, K. Elias, Hartmut Goldschmidt, Katja Weisel, Roland Fenk, Marc S. Raab, Fritz Van Rhee, Saad Z. Usmani, Kenneth H. Shain, Niels Weinhold, Gareth J. Morgan, Ola Landgren - Journal of Clinical Oncology 2024 cited by 119

  6. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

    Authors: Leo Rasche, Shweta S. Chavan, Owen Stephens, Pragi Patel, Ruslana G. Tytarenko, Cody Ashby, Michael Bauer, Joshua Epstein, S Deshpande, Christopher P. Wardell, Tímea Buzder, Gábor Molnár, Maurizio Zangari, Frits van Rhee, Sharmilan Thanendrarajan, Carolina Schinke, Joshua Epstein, Faith E. Davies, Brian A. Walker, Tobias Meißner, Bart Barlogie, Gareth J. Morgan, Niels Weinhold - Nature Communications 2017 cited by 419

  7. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

    Authors: Philippe Moreau, Shaji Kumar, Jesús F. San Miguel, Faith E. Davies, Elena Zamagni, Nizar J. Bahlis, Heinz Ludwig, Joseph Mıkhael, Evangelos Terpos, Fredrik Schjesvold, Thomas G. Martin, Kwee Yong, Brian G.M. Durie, Thierry Façon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels W.C.J. van de Donk, Sagar Lonial, Michèle Cavo, Sigurður Y. Kristinsson, Suzanne Lentzsch, Roman Hájek, Kenneth C. Anderson, Cristina João, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafaël Fonseca, Annette Juul Vangsted, Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf‐Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Paul G. Richardson - The Lancet Oncology 2021 cited by 268

  8. The genetic architecture of multiple myeloma

    Authors: Gareth J. Morgan, Brian A. Walker, Faith E. Davies - Nature reviews. Cancer 2012 cited by 919

  9. Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

    Authors: on behalf of the NCRI Haemato-oncology CSG, Vacha Shah, Amy L. Sherborne, Brian A. Walker, David C. Johnson, Eileen M. Boyle, Sidra Ellis, Dil Begum, Paula Proszek, John R Jones, Charlotte Pawlyn, Suvi Savola, Matthew Jenner, Mark T. Drayson, Roger G. Owen, Richard S. Houlston, David A. Cairns, Walter M. Gregory, Gordon Cook, Faith E. Davies, Graham Jackson, Gareth J. Morgan, Martin Kaiser - Leukemia 2017 cited by 235

  10. Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

    Authors: Graham Jackson, Faith E. Davies, Charlotte Pawlyn, David A. Cairns, Alina Striha, Corinne Collett, Anna Hockaday, John R Jones, Bhuvan Kishore, Mamta Garg, Cathy Williams, Kamaraj Karunanithi, Jindriska Lindsay, Matthew Jenner, Gordon Cook, Nigel H. Russell, Martin Kaiser, Mark T. Drayson, Roger G. Owen, Walter M. Gregory, Gareth J. Morgan - The Lancet Oncology 2018 cited by 340

  11. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

    Authors: Brian A. Walker, Christopher P. Wardell, Alex Murison, Eileen M. Boyle, Dil Begum, Nasrin M. Dahir, Paula Proszek, Lorenzo Melchor, Charlotte Pawlyn, Martin Kaiser, David C. Johnson, Ya‐Wei Qiang, John R Jones, David A. Cairns, Walter M. Gregory, Roger G. Owen, Gordon Cook, Mark T. Drayson, Graham Jackson, Faith E. Davies, Gareth J. Morgan - Nature Communications 2015 cited by 318

  12. Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk

    Authors: Ruth M. de Tute, Charlotte Pawlyn, David A. Cairns, Faith E. Davies, Tom Menzies, Andy C. Rawstron, John R. Jones, Anna Hockaday, Rowena Henderson, Gordon Cook, Mark T. Drayson, Matthew Jenner, Martin Kaiser, Walter M. Gregory, Gareth J. Morgan, Graham Jackson, Roger G. Owen - Journal of Clinical Oncology 2022 cited by 85

  13. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial

    Authors: Kevin Boyd, F. M. Ross, Laura Chiecchio, Gian Paolo Dagrada, Zoë J. Konn, William Tapper, Brian A. Walker, Christopher P. Wardell, Walter M. Gregory, Alexander J. Szubert, Sue Bell, J. Anthony Child, Graham Jackson, Faith E. Davies, Gareth J. Morgan, on behalf of the NCRI Haematology Oncology Studies Group - Leukemia 2011 cited by 346

  14. Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma

    Authors: Leo Rasche, Edgardo Angtuaco, James E. McDonald, Amy Buros, Caleb Stein, Charlotte Pawlyn, Sharmilan Thanendrarajan, Carolina Schinke, Rohan Samant, Shmuel Yaccoby, Brian A. Walker, Joshua Epstein, Maurizio Zangari, Frits van Rhee, Tobias Meißner, Hartmut Goldschmidt, Kari Hemminki, Richard S. Houlston, Bart Barlogie, Faith E. Davies, Gareth J. Morgan, Niels Weinhold - Blood 2017 cited by 248

  15. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma

    Authors: Eileen M. Boyle, Shayu Deshpande, Ruslana G. Tytarenko, Cody Ashby, Yan Wang, Michael Bauer, Sarah K. Johnson, Christopher P. Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Façon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H Rustad, Francesco Maura, Ola Landgren, Fenghuang Zhan, Frits van Rhee, Carolina Schinke, Faith E. Davies, Gareth J. Morgan, Brian A. Walker - Nature Communications 2021 cited by 138

  16. Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients

    Authors: Niels Weinhold, Hans Salwender, David A. Cairns, Marc S. Raab, George W. Waldron, Igor Wolfgang Blau, Uta Bertsch, Thomas Hielscher, Gareth J. Morgan, Anna Jauch, Faith E. Davies, Mathias Hänel, Gordon Cook, Christoph Scheid, Richard S. Houlston, Hartmut Goldschmidt, Graham Jackson, Martin Kaiser - Haematologica 2021 cited by 85

  17. Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells

    Authors: Anthony Tumber, Andrea Nuzzi, Edward S. Hookway, Stephanie B. Hatch, Srikannathasan Velupillai, C. Johansson, Akane Kawamura, P. Savitsky, Clarence Yapp, A. Szykowska, Na Wu, C. Bountra, Claire Strain‐Damerell, N. Burgess-Brown, G.F. Ruda, Oleg Fedorov, Shonagh Munro, Katherine S. England, Radosław P. Nowak, Christopher J. Schofield, Nicholas B. La Thangue, Charlotte Pawlyn, Faith E. Davies, Gareth J. Morgan, Nick Athanasou, Susanne Müller, Udo Oppermann, Paul E. Brennan - Cell chemical biology 2017 cited by 151

  18. The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states

    Authors: Leo Rasche, Carolina Schinke, Francesco Maura, Michael Bauer, Cody Ashby, Shayu Deshpande, Alexandra M. Poos, Maurizio Zangari, Sharmilan Thanendrarajan, Faith E. Davies, Brian A. Walker, Bart Barlogie, Ola Landgren, Gareth J. Morgan, Frits van Rhee, Niels Weinhold - Nature Communications 2022 cited by 76

  19. Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party

    Authors: Bradley Augustson, Gulnaz Begum, Janet Dunn, Nicola J. Barth, Faith E. Davies, Gareth J. Morgan, Judith Behrens, Alastair G. Smith, J. A. Child, Mark T. Drayson - Journal of Clinical Oncology 2005 cited by 490

  20. Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response

    Authors: Maruf M. U. Ali, Tina Bagratuni, Emma L. Davenport, Piotr Nowak, M. Cris Silva-Santisteban, Anthea Hardcastle, Craig McAndrews, Martin Rowlands, Gareth J. Morgan, Wynne Aherne, Ian Collins, Faith E. Davies, Laurence H. Pearl - The EMBO Journal 2011 cited by 252

  21. Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

    Authors: Leo Rasche, Daisy Alapat, Manoj Kumar, Grant Gershner, James E. McDonald, Christopher P. Wardell, Rohini Samant, Rudy Van Hemert, Joshua Epstein, Anjana Williams, Sharmilan Thanendrarajan, Carolina Schinke, Michael Bauer, Cody Ashby, Ruslana G. Tytarenko, Frits van Rhee, Brian A. Walker, Maurizio Zangari, Bart Barlogie, Faith E. Davies, Gareth J. Morgan, Niels Weinhold - Leukemia 2018 cited by 152

  22. Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level

    Authors: Carolina Schinke, Alexandra M. Poos, Michael Bauer, Lukas John, Sadie Johnson, Shayu Deshpande, Luis F. Carrillo, Daisy Alapat, Leo Rasche, Sharmilan Thanendrarajan, Maurizio Zangari, Samer Al Hadidi, Frits van Rhee, Faith E. Davies, Marc S. Raab, Gareth J. Morgan, Niels Weinhold - Blood Advances 2022 cited by 55

  23. Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens

    Authors: Francesco Maura, Eileen M. Boyle, David G. Coffey, Kylee Maclachlan, Dylan Gagler, Benjamin Diamond, Hussein Ghamlouch, Patrick Blaney, Bachisio Ziccheddu, Anthony Cirrincione, Monika Chojnacka, Yubao Wang, Ariel Siegel, James E. Hoffman, Dickran Kazandjian, Hani Hassoun, Emily Guzman, Sham Mailankody, Urvi A. Shah, Carlyn Tan, Malin Hultcrantz, Michael Scordo, Gunjan L. Shah, Heather Landau, David J. Chung, Sergio Giralt, Yanming Zhang, Arnaldo Arbini, Qi Gao, Mikhail Roshal, Ahmet Doǧan, Alexander M. Lesokhin, Faith E. Davies, Saad Z. Usmani, Neha Korde, Gareth J. Morgan, Ola Landgren - Nature Cancer 2023 cited by 51

  24. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

    Authors: Faith E. Davies, Noopur Raje, Teru Hideshima, Suzanne Lentzsch, Gloria Young, Yu‐Tzu Tai, Boris K. Lin, Klaus Podar, Deepak Gupta, Dharminder Chauhan, Steven P. Treon, Paul G. Richardson, Robert Schlossman, Gareth J. Morgan, George W. Muller, David Stirling, Kenneth C. Anderson - Blood 2001 cited by 905